Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-8-30
pubmed:abstractText
Natural killer (NK) cells kill normal and transformed hematopoietic cells that lack expression of major histocompatibility complex (MHC) class I antigens. Lysis of HLA-negative Epstein Barr virus-transformed B lymphoblastoid cell lines (B-LCL) by human NK cell clones can be inhibited by transfection of the target cells with certain HLA-A, -B, or -C alleles. NK cell clones established from an individual demonstrate clonal heterogeneity in HLA recognition and a single NK clone can recognize multiple alleles. We describe a potential human NK cell receptor (NKB1) for certain HLA-B alleles (e.g., HLA-B*5101 and-B*5801) identified by the mAb DX9. NKB1 is a 70-kD glycoprotein that is expressed on a subset of NK cells and NK cell clones. DX9 monoclonal antibody (mAb) specifically inhibits the interaction between NK cell clones and B-LCL targets transfected with certain HLA-B alleles, but does not affect recognition of HLA-A or HLA-C antigens. An individual NK cell clone can independently recognize B-LCL targets transfected with HLA-B or HLA-C antigens; however, DX9 mAb only affects interaction with transfectants expressing certain HLA-B alleles. These findings demonstrate the existence of NK cell receptors involved in the recognition of HLA-B and imply the presence of multiple receptors for MHC on an individual NK clone.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-1328466, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-1518825, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-1541831, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-1869832, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-1975828, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-2147946, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-2664068, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-2683611, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-2707298, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-2784569, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-2785140, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-3259252, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-3877776, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-3951539, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-6086760, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-6225799, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-7140810, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-8265660, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-8376937, http://linkedlifedata.com/resource/pubmed/commentcorrection/8046332-8493555
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-1007
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
180
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
537-43
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.
pubmed:affiliation
Department of Human Immunology, DNAX Research Institute of Molecular and Cellular Biology, Inc., Palo Alto, California 94304.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't